Research directory
Below are clinical trials currently recruiting participants in the United States.
125 studies
Recently updated first
NCT07196722
A randomized study of daily oral icotrokinra or placebo in adults with moderately to severely active Crohn’s disease.
Crohn Disease
361 recruiting sites
Updated Jul 31, 2026
NCT07196748
A phase 3 study of oral icotrokinra in adults and adolescents with moderately to severely active ulcerative colitis.
Colitis, Ulcerative
389 recruiting sites
Updated Jul 31, 2026
NCT07499232
A randomized study comparing guselkumab with risankizumab in adults with moderately to severely active Crohn’s disease.
Crohn Disease
143 recruiting sites
Updated Jul 31, 2026
NCT07577843
A Phase 3 study comparing JNJ-78934804 with guselkumab in adults with moderately to severely active Crohn’s disease.
Crohn Disease
55 recruiting sites
Updated Jul 31, 2026
NCT07577856
Phase 3 study comparing JNJ-78934804 with guselkumab in adults with moderately to severely active ulcerative colitis.
Colitis, Ulcerative
63 recruiting sites
Updated Jul 31, 2026
NCT06598943
A Phase 2 study of eltrekibart, mirikizumab, and their combination in adults with moderately to severely active ulcerative colitis.
Ulcerative Colitis · Ulcerative Colitis Chronic
207 recruiting sites
Updated Jul 30, 2026
NCT06979336
Phase 2 study of RO7837195 versus placebo in adults with active ulcerative colitis after conventional or advanced therapies failed.
Ulcerative Colitis
103 recruiting sites
Updated Jul 28, 2026
NCT07012395
A Phase 2 study of three experimental antibodies, alone or combined, in adults with moderately to severely active ulcerative colitis.
Colitis · Colitis, Ulcerative · Inflammatory Bowel Diseases · Ulcerative Colitis
259 recruiting sites
Updated Jul 28, 2026
NCT03219359
A phase 2 study of stem cell transplant followed by vedolizumab in adults with active, treatment-refractory Crohn's disease.
Crohn Disease
1 recruiting site
Updated Jul 24, 2026
NCT06619990
XmAb942 or placebo is being studied in healthy adults and adults with moderate-to-severe active ulcerative colitis.
Ulcerative Colitis (UC)
88 recruiting sites
Updated Jul 24, 2026
NCT05076175
A randomized study of oral ozanimod in children with moderate to severe active ulcerative colitis that has not responded adequately to conventional therapy.
Colitis, Ulcerative
50 recruiting sites
Updated Jul 23, 2026
NCT07456566
A pilot trial of a 24-week digital self-management program alongside standard care for adults with active inflammatory bowel disease.
Crohn Disease · Inflammatory Bowel Diseases · Ulcerative Colitis
1 recruiting site
Updated Jul 23, 2026
NCT06420375
A Phase 2 crossover study of oral BRS201 and placebo in adults with active mild ulcerative colitis.
Ulcerative Colitis · Ulcerative Colitis Mild
1 recruiting site
Updated Jul 21, 2026
NCT07170462
This study compares daily cranberry powder with placebo in Massachusetts adults with Crohn's disease.
Crohn Disease · Crohn Disease (CD)
1 recruiting site
Updated Jul 20, 2026
NCT06997965
Phase 4 study of mirikizumab in adults with Crohn disease and inflammatory intestinal strictures.
Crohn Disease
3 recruiting sites
Updated Jul 16, 2026
NCT07337902
A pilot study comparing acetaminophen and ibuprofen for period cramps in adults with Crohn's disease.
Crohn's Disease (CD) · Dysmenorrhea Primary
1 recruiting site
Updated Jul 14, 2026
NCT07296315
A Phase 2 study comparing two doses of MH002 with placebo in people with mild-to-moderate ulcerative colitis.
Colitis, Ulcerative
16 recruiting sites
Updated Jul 9, 2026
NCT05287126
A Phase 2 study of daily oral etrasimod in adolescents ages 12–17 with moderately to severely active ulcerative colitis.
Ulcerative Colitis
44 recruiting sites
Updated Jul 8, 2026
NCT05923073
Phase 3 study of intravenous or subcutaneous guselkumab in children ages 2–17 with moderately to severely active Crohn’s disease.
Crohn's Disease
83 recruiting sites
Updated Jul 6, 2026
NCT06233461
A placebo-controlled study of three TAK-279 doses in adults with moderately to severely active Crohn’s disease.
Crohn's Disease
187 recruiting sites
Updated Jul 6, 2026
